1 project

Preventing fatal complications of COVID-19 with novel SkQ1 treatment

Accumulating evidence suggests that a subgroup of patients with severe COVID-19 might have a cytokine storm syndrome that leads to hyperinflammation of their lung tissue. Challenge is how to interrupt this hyperinflammation without critically suppressing immune system. SkQ1 compound developed by Mitotech SA (Luxembourg) has shown to interrupt cytokine storm in animal models and may be irreplaceable in preventing fatalities in COVID-19.

export results as excel

MESR FNR University of Luxembourg LIST LISER LIH